Adverse Event Associated with Turmeric Preparation : Consumer Reporting Experiences by Mrs. Wimon Suwankesawong Thai Adverse Product Reaction Monitoring.

Slides:



Advertisements
Similar presentations
The management of adverse drug reactions I Ralph Edwards
Advertisements

Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Managing Side Effects of TKIs
Antihypertensives By: Carolyne Barnes 5/6/09. Facts! Antihypertensives are medications used to treat high blood pressure. High blood pressure is a sign.
Overview of Aspirin and NSAID’s Label Warnings William E. Gilbertson, PharmD. Division OTC Drug Products 1.
1 Chapter 8 Drugs for Gastrointestinal Disorders.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 41- Lower Gastrointestinal System.
Sudden Illness When illness happens suddenly, it is hard to determine what is wrong and what you should do to help.
Overview of the Clinical Development EMBEDA™ (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use. ASENT 12 th Annual.
Hepatitis web study Hepatitis web study Hepatitis web study Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir +/- RBV in GT1b PEARL-II.
Hepatitis web study Hepatitis web study Hepatitis web study Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir + RBV in Liver Transplant.
Inference about a population proportion Chapter 20 © 2006 W.H. Freeman and Company.
Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence Phase 2 Curry MP, et al. Gastroenterology. 2015;148:100-7.
Hepatitis web study Hepatitis web study Ledipasvir-Sofosbuvir + RBV in Sofosbuvir-Experienced HCV GT1 Retreatment of Sofosbuvir Failures Phase 2 Treatment.
Hepatitis web study Hepatitis web study 3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1 CORAL-I Phase 2 Treatment Naïve and Treatment Experienced.
Hepatitis web study Hepatitis web study 3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) +/- RBV in GT1b PEARL-II Phase 3 Treatment Experienced Andreone.
Hepatitis web study Hepatitis web study 3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in GT1 SAPPHIRE-II Phase 3 Treatment Experienced Zeuzem.
Canine NSAIDs—What Dog Owners Should Know
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
Ohio Pesticide Applicator Training
Clinical Pathological Conference Kartikya Ahuja, M.D. Resident Physician Department of Medicine NYU School of Medicine July 20 th, 2007.
COMPARISON OF BIOAVAILABILITY OF DIFFERENT FORMS OF CURCUMIN USING NON-EVERTED RAT INTESTINAL SAC MODEL.
Chapter 29 Central Nervous System Stimulants Used to Treat Attention Deficit Hyperactivity Disorder and Agents Used to Treat Alzheimer’s Disease.
Factors Affecting Drug Activity Chapter 11 Pages
Medications for Pain Management and Anesthesia Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. Chapter 17 1.
Adverse Event Tracking as mandated by the Best Pharmaceuticals for Children Act Dr. Solomon Iyasu Medical Team Leader Division of Pediatric Drug Development.
 Coeliac disease is an autoimmune disorder of the small intestine that occurs in genetically predisposed people of all ages from middle infancy onward.
1 One Year Post Exclusivity Adverse Event Review: Ofloxacin Ophthalmic Pediatric Advisory Committee Meeting September 15, 2004 Hari Cheryl Sachs, MD, FAAP.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Measuring the Severity of Medication Discrepancies: A Community Pharmacy Perspective.
Ibuprofen Nicole Escudero. Why do people choose to use Ibuprofen?
DRUGS USED IN HYPOTHYROIDISM. Objectives At the end of the lecture the students will be able to : At the end of the lecture the students will be able.
Pharmacology 3 Safety and Effectiveness in Medicines Administration Applying the Evidence Base.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 15 Antifungal Drugs.
Comparison of Bromfenac vs. Ketorolac During the Induction Phase of Treatment with Topical Cyclosporine for Dry Eye Patients Barry A. Schechter, MD Florida.
OBV/PTV/r + DSV + RBV OBV/PTV/r + DSV Randomisation* 1 : 1 Open label years Chronic HCV infection Genotype 1b Prior failure to PEG-IFN + RBV HCV.
Author Name: Kannika Inpra Presenter Name: Kannika Inpra Authors: Inpra K., Suwankesawong W., Kaewvichit S. Institution: Phrae.
Egyptian Ancestry  Design  Objective –SVR 12 (HCV RNA < 25 IU/ml), with 95% CI SOF 400 mg qd + RBV Randomised 1 : 1 Open-label Egyptian Ancestry Study:
Rivastigmine Tartrate Presented by: Mona Abdulrahman Alkallabi Mona Abdulrahman Alkallabi.
A MEDICINE CABINET IN YOUR KITCHEN
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
Brought to you by: Ashley Renn. Understand what a supplement is Learn the difference between vitamins, minerals, and herbs How to know if you need one.
Drugs for the Treatment of Pain
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 16 Central Nervous System Stimulants and Related.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 22 Antianxiety Drugs.
HW 499 Vitamins, Herbs and Nutritional Supplements.
AGGRENOX TM Safety Head, Drug Surveillance and Information Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Connecticut Kenneth Rakowski, MD.
Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Diseases
Chapter 29 Central Nervous System Stimulants Used to Treat Attention Deficit Hyperactivity Disorder and Agents Used to Treat Alzheimer’s Disease.
Food Allergies.
Medication Lists and Questions You Should Be Asking Your Doctor and Pharmacist Reduce Risk of Medication Errors and Adverse Drug Events Medication Chest.
Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence Phase 2 Curry MP, et al. Gastroenterology. 2014;September.
Adverse Event Associated with Turmeric Preparation : Consumer Reporting Experiences by Mrs. Wimon Suwankesawong Thai Adverse Product Reaction Monitoring.
C-1 Safety Results S. aureus Bacteremia and Endocarditis Study Gloria Vigliani, M.D. Vice President, Medical Strategy Cubist Pharmaceuticals.
Success rate ≥ Default rate < Transfer-out rate Failure rate≤ Death rate
Poisoning. Ingested Poisons Recognizing ingested poisoning –Abdominal pain –Nausea or vomiting –Diarrhea –Burns, stains, odor near or in mouth –Drowsiness.
 Inhalation  Ingestion  Absorption  Injection.
Do not agonize any kind of pain, take Ultram Tramadol.
Adverse events following immunization of pregnant
Chapter 19: Medicines and Drugs
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
GS-US Study: SOF/VEL + GS in genotype 2, 3, 4 or 6 - Phase II
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Problems of Irrational Drug Use
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
Acid-peptic disease   A group of disorders involving erosion or ulceration of the mucosal lining of the gastrointestinal tract; includes GERD, gastric.
New Models of Care in Idiopathic Pulmonary Fibrosis
Presentation transcript:

Adverse Event Associated with Turmeric Preparation : Consumer Reporting Experiences by Mrs. Wimon Suwankesawong Thai Adverse Product Reaction Monitoring Center Food and Drug Administration Thailand

 Turmeric, Curcuma longa Linn., is a herbal plant extensively cultivated in Thailand Introduction (1)  Its rhizome is used in traditional medicines for many indications  Major chemical constituents of rhizomes are volatile oil (6%) and curcumenoids(5%)

 In 1999,the single formulation of turmeric was selected as herbal medicine for the Thai National Essential Drug List for anti-flatulence mg powder of dried turmeric rhizome Introduction (2)

 Turmeric is believed to be effective and safe  adverse effect : nausea, vomiting diarrhea constipation, pruritus, headache, dizziness, palpitation  Curcumin, an active ingredient in turmeric, has been reported to induce gastric ulceration in rats Introduction (3)

Objective  To investigate and categorize adverse events associated with turmeric preparations Study design  Prospective time-series design

Method (1)  Setting and Study population  Patients who were prescribed turmeric products during April 1, 2001-March 30,2003 in fifty government hospitals were enrolled in the study

Data collection  Hospital pharmacist interviewed the patients to collect baseline data  Patients were asked to send back a postcard with structured questions after 1-2 weeks to report their experience using turmeric products  Effectiveness  Adverse event Method (2)

Demographic Data  Patients taking turmeric product= 978  Lost to follow up= 342 (35%)  Study population= 636  Patient with adverse event= 220 (34.6%)  Female= 158 (71.8%)  Mean age = 48  Underlying disease= 126  Number of adverse events= 479  None of serious adverse event

Adverse Events classified by System Organ Class (1) System-organ classes n=479 (%) GI system disorders186 (38.83)  abdominal pain, n/v, anorexia, diarrhea Body as a whole-general 148 (30.90) disorders  fatigue, chest discomfort, therapeutic response decreased(ineffective)

Adverse Events classified by System Organ Class (2) System-organ classes n=479 (%) Central & peripheral nervous 51 (10.82) system disorder  headache, dizziness Respiratory system disorders 48 (10.02)  dyspnoea,cough Skin and appendages disorders 32 (0.84)  rash, pruritus

Discussion  Lost to follow up  Direct consumer reporting system : awareness of reporting  None or Mild adverse event  GI system disorder  Volatile oil : stomach distress  Patients with underlying disease : Peptic Ulcer  Quality of products : ineffective  Patient Compliance : low

Conclusion & Recommendaton  Single turmeric product : safe  GI system disorder  Further study  GI system disorder associated with single turmeric preparation are needed  be used to Label the product accurately to promote national and safe use of the product